Cargando…
Estrogen as therapy for breast cancer
High-dose estrogen was generally considered the endocrine therapy of choice for postmenopausal women with breast cancer prior to the introduction of tamoxifen. Subsequently, the use of estrogen was largely abandoned. Recent clinical trial data have shown clinically meaningful efficacy for high-dose...
Autor principal: | Ingle, James N |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC138731/ https://www.ncbi.nlm.nih.gov/pubmed/12100736 http://dx.doi.org/10.1186/bcr436 |
Ejemplares similares
-
The origins of estrogen receptor alpha-positive and estrogen receptor alpha-negative human breast cancer
por: Allred, D Craig, et al.
Publicado: (2004) -
Estrogen receptor-beta sensitizes breast cancer cells to the anti-estrogenic actions of endoxifen
por: Wu, Xianglin, et al.
Publicado: (2011) -
Estrogen–progestin replacement therapy: regulatory action needed
por: Pike, Malcolm C, et al.
Publicado: (2002) -
Intrauterine exposures, pregnancy estrogens and breast cancer risk: where do we currently stand?
por: Lagiou, Pagona
Publicado: (2006) -
Pharmacogenomics of endocrine therapy in breast cancer
por: Ingle, James N
Publicado: (2013)